Lv11
10 积分 2025-08-07 加入
CD137 (4-1BB)-Based Cancer Immunotherapy on Its 25th Anniversary
32分钟前
待确认
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
18天前
已完结
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
1个月前
已完结
In vivo CAR engineering for immunotherapy
1个月前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
1个月前
已完结
皖公网安备34019202002308
